Regulatory Affairs Executive I CMC I Biosimilars

Ahmedabad, Gujarat, India



Master of Science, Biotechnology
bangalore university
Bachelor of Science, Biotechnology, Genetics, Biochemistry
The Oxford College of Science, Bengaluru
Join Arunima and 10k+ other professionals on
Tal is the app where bosses meet engineers & builders directly, without middlemen
Download Tal BossRegulatory Affairs Executive I CMC I Biosimilars
Regulatory Affairs professional with expertise in global biosimilar submissions and early-stage advanced therapies (CGT), integrating prior hands-on scientific experience in downstream processing and formulation development with strategic regulatory capabilities for accelerated global approvals. Passionate about bridging laboratory insights with regulatory digital transformation to deliver robust dossiers advancing safe and effective medicines worldwide.
Ahmedabad
Regulatory Affairs Executive at Intas Pharmaceuticals, Mar 2025 - Present · 1 yr 2 mos, Ahmedabad, Gujarat, India, • Managed regulatory submissions for biosimilar mAbs and CGT products across global (EMA MAA, IMPD), emerging, and domestic markets (Phase I CTA). • Authored and reviewed CMC modules (2.3, 3) and Administrative/Regional Information Module 1, evaluated Non-Clinical Overview module (2.4) and Clinical modules (2.5, 2.7) for regulatory readiness. • Handled Day 120 LoQ and Day 180 LoOI responses through CMC writing, cross-functional leadership, CHMP scientific advice assessment, and review of eAF, cover letters, and artworks. • Supported early-stage FDA BLA preparation through Agreed iPSP submission and preliminary checklist development. • Experienced in change control assessments, eCTD structure readiness for publishing and validation and risk registry preparation.
Scientist at Biocon Biologics, Sep 2023 - Feb 2025 · 1 yr 6 mos, Responsible for Downstream purification process development for biosimilar insulin analogs including crystallization studies and in-process protein analysis using preparative chromatography and analytical HPLC. Implemented DOE studies for purification optimization and integrated experimental data with project objectives.
Intern at Biocon Biologics, Mar 2023 - Sep 2023 · 7 mos, Hands-on experience in biosimilar mAb drug product formulation and development through pre-formulation studies, stability studies, and forced degradation studies across multiple stress conditions. Conducted analysis of in-process samples and finished products using SEC, cIEF, CE-SDS, and physico-chemical techniques.
Master of Science, Biotechnology, bangalore university
Bachelor of Science, Biotechnology, Genetics, Biochemistry, The Oxford College of Science, Bengaluru